| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $442.1M | +29.2% |
| Cost of Revenue | $355.2M | +30.3% |
| Gross Profit | $86.9M | +24.8% |
| R&D Expense | $14.6M | -2.8% |
| SG&A Expense | $74.9M | +55.9% |
| Operating Income | -$2.6M | -139.3% |
| Pre-tax Income | $95.5M | +4292.2% |
| Income Tax | -$28.0M | — |
| Net Income | $118.9M |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.2M | +23.2% |
| Accounts Receivable | $100.1M | +84.2% |
| Inventory | $24.6M | +69.2% |
| Current Assets | $193.2M | +46.3% |
| Total Assets | $733.9M | +133.9% |
| Current Liabilities | $324.0M | +110.0% |
| Long-term Debt | $38.9M | -2.3% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.0M | -256.9% |
| Capital Expenditures | $24.3M | +206.4% |
| Investing Cash Flow | -$113.0M | -908.9% |
| Financing Cash Flow | $146.4M | +2254.7% |
| Free Cash Flow | -$53.3M | -606.7% |
| +1850.5% |
| EPS (Basic) | $2.47 | +1864.3% |
| EPS (Diluted) | $2.44 | +1842.9% |
| Total Liabilities |
| $538.1M |
| +115.0% |
| Stockholders' Equity | $187.8M | +226.0% |